UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Colorectal tumor comorbidity is common in patients with duodenal tumors: Exploratory cross-sectional study

Endoscopy International Open, 2024-10, Vol.12 (10), p.E1206-E1213

2024

Volltextzugriff (PDF)

Pirtobrutinib in Relapsed/Refractory CLL/SLL: Results From BTK-Naïve Cohort in the Phase 1/2 BRUIN Study

Clinical lymphoma, myeloma and leukemia, 2024-09, Vol.24, p.S181-S181

2024

Volltextzugriff (PDF)

CLL-269 Pirtobrutinib in Relapsed/Refractory CLL/SLL: Results From BTK-Naïve Cohort in the Phase 1/2 BRUIN Study

Clinical lymphoma, myeloma and leukemia, 2024-09, Vol.24, p.S350-S350

2024

Volltextzugriff (PDF)

Heterogeneity or change in cell of origin in diffuse large B-cell lymphomas determined using hans algorithm

Human pathology, 2024-09, Vol.151, p.105630, Article 105630

2024

Volltextzugriff (PDF)

Plasma Venetoclax Concentrations in Patients with Acute Myeloid Leukemia Treated with CYP3A4 Inhibitors

YAKUGAKU ZASSHI (Journal of the Pharmaceutical Society of Japan), 2024-07, Vol.144 (7), p.775-779

2024

Volltextzugriff (PDF)

Plasma Venetoclax Concentrations in Patients with Acute Myeloid Leukemia Treated with CYP3A4 Inhibitors

YAKUGAKU ZASSHI, 2024/07/01, Vol.144(7), pp.775-779

2024

Volltextzugriff (PDF)

EVALUATION OF APPROPRIATE NASO-PANCREATIC DUCT DRAINAGE AFTER ENDOSCOPIC SUBMUCOSAL DISSECTION FOR LARGE LATERALLY SPREADING TUMOR INVOLVING THE PAPILLA: A SINGLE-CENTER RETROSPECTIVE STUDY

Gastrointestinal endoscopy, 2024-06, Vol.99 (6), p.AB712-AB712

2024

Volltextzugriff (PDF)

Abstract CT115: A first-in-human phase I study of CTX-712 in patients with advanced, relapsed or refractory malignant tumors (CTX-712-CL-01 study): Efficacy and safety in a hematologic malignancies cohort

Cancer research (Chicago, Ill.), 2024-04, Vol.84 (7_Supplement), p.CT115-CT115

2024

Volltextzugriff (PDF)

Rational in silico design identifies two mutations that restore UT28K SARS-CoV-2 monoclonal antibody activity against Omicron BA.1

Structure (London), 2024-03, Vol.32 (3), p.263-272.e7

2024

Volltextzugriff (PDF)

Diffuse large B-cell lymphoma of the skull vault

International journal of hematology, 2024-03, Vol.119 (3), p.215-216

2024

Volltextzugriff (PDF)

Loss of or decrease in CD30 expression in four patients with anaplastic large cell lymphoma after brentuximab vedotin-containing therapy

Virchows Archiv : an international journal of pathology, 2024-03, Vol.484 (3), p.465-473

2024

Volltextzugriff (PDF)

Japanese phase Ib study of the oral PI3K-δ and -γ inhibitor duvelisib in patients with relapsed or refractory chronic lymphocytic leukemia or small lymphocytic lymphoma

International journal of hematology, 2024-02, Vol.119 (2), p.156-163

2024

Volltextzugriff (PDF)

Phase 2 study of ibrutinib plus venetoclax in Japanese patients with relapsed/refractory mantle cell lymphoma

International journal of clinical oncology, 2024-02, Vol.29 (2), p.232-240

2024

Volltextzugriff (PDF)

Preface

Rinshō ketsueki, 2024, Vol.65 (5), p.340

Fukuhara, Noriko

2024

Volltextzugriff (PDF)

Alemtuzumab monotherapy for T-cell prolymphocytic leukemia: an observational study in Japan

Journal of Clinical and Experimental Hematopathology, 2024, pp.24028

2024

Volltextzugriff (PDF)

Three-year follow-up analysis of phase 1/2 study on tirabrutinib in patients with relapsed or refractory primary central nervous system lymphoma

Neuro-oncology advances, 2024-01, Vol.6 (1), p.vdae037-vdae037

2024

Volltextzugriff (PDF)

Successful Cord Blood Transplantation for Myeloid/Natural Killer Precursor Acute Leukemia: A Case Report and Literature Review

Internal Medicine, 2024, pp.4221-24

2024

Volltextzugriff (PDF)

Real-world retrospective analysis of immune checkpoint inhibitor therapy for relapsed or refractory Hodgkin’s lymphoma

Journal of Clinical and Experimental Hematopathology, 2024, pp.24021

2024

Volltextzugriff (PDF)

Enhancement of recombinant adeno-associated virus activity by improved stoichiometry and homogeneity of capsid protein assembly

Molecular therapy. Methods & clinical development, 2023-12, Vol.31, p.101142-101142, Article 101142

2023

Volltextzugriff (PDF)

Post-Hoc Analysis of the Final, Three-Year Follow-up Results of a Phase I/II Study on Tirabrutinib (ONO-4059) in Patients with Relapsed or Refractory Primary Central Nervous System Lymphoma

Blood, 2023-11, Vol.142 (Supplement 1), p.4472-4472

2023

Volltextzugriff (PDF)

Transcription Factor GATA2 Is Inevitable for the Survival and Proper Differentiation of Thymic Multipotent Progenitor Cells By Gene Expression Orchestration

Blood, 2023-11, Vol.142 (Supplement 1), p.1182-1182

2023

Volltextzugriff (PDF)

Impact of Mogamulizumab-Containing Chemotherapy on HBV Reactivation in Patients with T-Cell Lymphoma: A Multicenter Retrospective Observational Study (PROACTIVE-MOGA)

Blood, 2023-11, Vol.142 (Supplement 1), p.6192-6192

2023

Volltextzugriff (PDF)

Roles for Heme Synthesis in the Maintenance of Hematopoietic Stem and Progenitor Cells

Blood, 2023-11, Vol.142 (Supplement 1), p.2682-2682

2023

Volltextzugriff (PDF)

1 – 25 von 311

Suche als RSS-Feed

Aktive Filter

ThemaAdult

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(265)
Mit Volltextzugriff
(285)

Publikationsform

Sprache

Englisch
(284)
Japanisch
(32)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Colorectal tumor comorbidity is common in patients with duodenal tumors: Exploratory cross-sectional study

Pirtobrutinib in Relapsed/Refractory CLL/SLL: Results From BTK-Naïve Cohort in the Phase 1/2 BRUIN Study

CLL-269 Pirtobrutinib in Relapsed/Refractory CLL/SLL: Results From BTK-Naïve Cohort in the Phase 1/2 BRUIN Study

Heterogeneity or change in cell of origin in diffuse large B-cell lymphomas determined using hans algorithm

Plasma Venetoclax Concentrations in Patients with Acute Myeloid Leukemia Treated with CYP3A4 Inhibitors

Plasma Venetoclax Concentrations in Patients with Acute Myeloid Leukemia Treated with CYP3A4 Inhibitors

Oral azacitidine compared with standard therapy in patients with relapsed or refractory follicular helper T-cell lymphoma (ORACLE): an open-label randomised, phase 3 study

EVALUATION OF APPROPRIATE NASO-PANCREATIC DUCT DRAINAGE AFTER ENDOSCOPIC SUBMUCOSAL DISSECTION FOR LARGE LATERALLY SPREADING TUMOR INVOLVING THE PAPILLA: A SINGLE-CENTER RETROSPECTIVE STUDY

Abstract CT115: A first-in-human phase I study of CTX-712 in patients with advanced, relapsed or refractory malignant tumors (CTX-712-CL-01 study): Efficacy and safety in a hematologic malignancies cohort

Rational in silico design identifies two mutations that restore UT28K SARS-CoV-2 monoclonal antibody activity against Omicron BA.1

Diffuse large B-cell lymphoma of the skull vault

Loss of or decrease in CD30 expression in four patients with anaplastic large cell lymphoma after brentuximab vedotin-containing therapy

Japanese phase Ib study of the oral PI3K-δ and -γ inhibitor duvelisib in patients with relapsed or refractory chronic lymphocytic leukemia or small lymphocytic lymphoma

Phase 2 study of ibrutinib plus venetoclax in Japanese patients with relapsed/refractory mantle cell lymphoma

Preface

Alemtuzumab monotherapy for T-cell prolymphocytic leukemia: an observational study in Japan

Three-year follow-up analysis of phase 1/2 study on tirabrutinib in patients with relapsed or refractory primary central nervous system lymphoma

Successful Cord Blood Transplantation for Myeloid/Natural Killer Precursor Acute Leukemia: A Case Report and Literature Review

Real-world retrospective analysis of immune checkpoint inhibitor therapy for relapsed or refractory Hodgkin’s lymphoma

Enhancement of recombinant adeno-associated virus activity by improved stoichiometry and homogeneity of capsid protein assembly

Post-Hoc Analysis of the Final, Three-Year Follow-up Results of a Phase I/II Study on Tirabrutinib (ONO-4059) in Patients with Relapsed or Refractory Primary Central Nervous System Lymphoma

Transcription Factor GATA2 Is Inevitable for the Survival and Proper Differentiation of Thymic Multipotent Progenitor Cells By Gene Expression Orchestration

Impact of Mogamulizumab-Containing Chemotherapy on HBV Reactivation in Patients with T-Cell Lymphoma: A Multicenter Retrospective Observational Study (PROACTIVE-MOGA)

Roles for Heme Synthesis in the Maintenance of Hematopoietic Stem and Progenitor Cells

Survival and CNS Relapse in Patients with CD5-Positive Diffuse Large B-Cell Lymphoma: A Multi-Institutional Observational Study in Japan

Aktive Filter

Suchergebnisse filtern